Across 61 first-hand reports, people mentioned a side effect 8 times (about 13 per 100 reports). The most common: fatigue, slow wound, canker sores. User reports show what people notice — they can't tell you whether Rapamycin is safe for you.
“I've noticed a 10% increase in HDL and some fatigue the day after taking more than 6mg.”
“My skin looks great, my metabolic profile is great, blood pressure is great”
“I take 6mg Rapa once a week. I also take 1300mg Ashawaganda... Lately I have had stomach loose bowel issues”
Conclusion: The majority of the patients reported adverse events limited to grade 1 or 2. On the whole, the data presented herein confirm the findings of previous studies on the relative safety of everolimus, a targeted therapeutic agent, which differs from that of conventional chemotherapy, and highlight the potential adverse events associated with the therapeutic use of everolimus.
Conclusion: Among patients undergoing DCB-only PCI, the risk of TLF was similar during 9-12 months of follow-up after PCB and SCB treatment. However, the MLD was larger favoring PCB over SCB on follow-up angiography.